Liver abscess

References

Key articles

Kaplan GG, Gregson DB, Laupland KB. Population-based study of the epidemiology of and the risk factors for pyogenic liver abscess. Clin Gastroenterol Hepatol. 2004 Nov;2(11):1032-8.Full text  Abstract

Johannsen EC, Sifri CD, Madoff LC. Pyogenic liver abscesses. Infect Dis Clin North Am. 2000 Sep;14(3):547-63. Abstract

Kim AY, Chung RT. Bacterial, parasitic, and fungal infections of the liver, including liver abscess. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's gastrointestinal and liver disease: pathophysiology diagnosis management. Philadelphia, PA: Elsevier Saunders; 2010:1351-69.

Haque R, Huston CD, Hughes M, et al. Amebiasis. New Engl J Med. 2003 Apr 17;348(16):1565-73. Abstract

Stanley SL Jr. Amoebiasis. Lancet. 2003 Mar 22;361(9362):1025-34. Abstract

Reference articles

1. Kaplan GG, Gregson DB, Laupland KB. Population-based study of the epidemiology of and the risk factors for pyogenic liver abscess. Clin Gastroenterol Hepatol. 2004 Nov;2(11):1032-8.Full text  Abstract

2. Mohsen AH, Green ST, Read RC, et al. Liver abscess in adults: ten years experience in a UK centre. QJM. 2002 Dec;95(12):797-802.Full text  Abstract

3. Alvarez J, González J, Baldonedo R, et al. Pyogenic liver abscesses: a comparison of older and younger patients. HPB (Oxford). 2001;3(3):201-6.Full text  Abstract

4. Meddings L, Myers RP, Hubbard J, et al. A population-based study of pyogenic liver abscesses in the United States: incidence, mortality, and temporal trends. Am J Gastroenterol. 2010 Jan;105(1):117-24. Abstract

5. Huang CJ, Pitt HA, Lipsett PA, et al. Pyogenic hepatic abscess: changing trends over 42 years. Ann Surg. 1996 May;223(5):600-7.Full text  Abstract

6. Johannsen EC, Sifri CD, Madoff LC. Pyogenic liver abscesses. Infect Dis Clin North Am. 2000 Sep;14(3):547-63. Abstract

7. Tsai FC, Huang YT, Chang LY, et al. Pyogenic liver abscess as endemic disease, Taiwan. Emerg Infect Dis. 2008 Oct;14(10):1592-600.Full text  Abstract

8. Kim JK, Chung DR, Wie SH, et al. Risk factor analysis of invasive liver abscess caused by the K1 serotype Klebsiella pneumoniae. Eur J Clin Microbiol Infect Dis. 2009 Jan;28(1):109-11. Abstract

9. Petri WA Jr, Singh U. Diagnosis and management of amebiasis. Clin Infect Dis. 1999 Nov;29(5):1117-25.Full text  Abstract

10. Snider C, Petri WA Jr. Travel medicine. In: Rakel RE, ed. Conn's current therapy. 61st ed. New York, NY: W.B. Saunders; 2008:156-64.

11. Johnston V, Stockley JM, Dockrell D, et al; British Infection Society and the Hospital for Tropical Diseases. Fever in returned travellers presenting in the United Kingdom: recommendations for investigation and initial management. J Infect. 2009 Jul;59(1):1-18. Abstract

12. Jepsen P, Vilstrup H, Schønheyder HC, et al. A nationwide study of the incidence and 30-day mortality rate of pyogenic liver abscess in Denmark, 1977-2002. Aliment Pharmacol Ther. 2005 May 15;21(1):1185-8.Full text  Abstract

13. Rahimian J, Wilson T, Oram V, et al. Pyogenic liver abscess: recent trends in etiology and mortality. Clin Infect Dis. 2004;39:1654-1659.Full text  Abstract

14. Fang CT, Lai SY, Yi WC, et al. Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin Infect Dis. 2007 Aug 1;45(3):284-93.Full text  Abstract

15. Lederman ER, Crum NF. Pyogenic liver abscess with a focus on Klebsiella pneumoniae as a primary pathogen: an emerging disease with unique clinical characteristics. Am J Gastroenterol. 2005 Feb;100(2):322-31. Abstract

16. Rockey DC. Hepatobiliary infections. Curr Opin Gastroenterol. 2001 Jul;17(1):257-61. Abstract

17. Kim AY, Chung RT. Bacterial, parasitic, and fungal infections of the liver, including liver abscess. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's gastrointestinal and liver disease: pathophysiology diagnosis management. Philadelphia, PA: Elsevier Saunders; 2010:1351-69.

18. Leggieri N, Marques-Vidal P, Cerwenka H, et al. Migrated foreign body liver abscess: illustrative case report, systematic review, and proposed diagnostic algorithm. Medicine (Baltimore). 2010 Mar;89(2):85-95. Abstract

19. Thomsen RW, Jepsen P, Sørensen HT. Diabetes mellitus and pyogenic liver abscess: risk and prognosis. Clin Infect Dis. 2007 May 1;44(9):1194-201.Full text  Abstract

20. Molle I, Thulstrup AM, Vilstrup H, et al. Increased risk and case fatality rate of pyogenic liver abscess in patients with liver cirrhosis: a nationwide study in Denmark. Gut. 2001 Feb;48(2):260-3. Abstract

21. Shibata T, Yamamoto Y, Yamamoto N, et al. Cholangitis and liver abscess after percutaneous ablation therapy for liver tumors: incidence and risk factors. J Vasc Interv Radiol. 2003 Dec;14(12):1535-42. Abstract

22. Alvarez Pérez JA, González JJ, Baldonedo RF, et al. Clinical course, treatment, and multivariate analysis of risk factors for pyogenic liver abscess. Am J Surg. 2001 Feb;181(2):177-86. Abstract

23. Law ST, Li KK. Role of C-reactive protein in response-guided therapy of pyogenic liver abscess. Eur J Gastroenterol Hepatol. 2014 Feb;26(2):179-86. Abstract

24. American College of Radiology. ACR Appropriateness Criteria: acute nonlocalized abdominal pain. 2018 [internet publication].Full text

25. Everts RJ, Heneghan JP, Adholla PO, et al. Validity of cultures of fluid collected through drainage catheters versus those obtained by direct aspiration. J Clin Microbiol. 2001 Jan;39(1):66-8.Full text  Abstract

26. Chemaly RF, Hall GS, Keys TF, et al. Microbiology of liver abscesses and the predictive value of abscess gram stain and associated blood cultures. Diagn Microbiol Infect Dis. 2003 Aug;46(4):245-8. Abstract

27. Lin AC, Yeh DY, Hsu YH, et al. Diagnosis of pyogenic liver abscess by abdominal ultrasonography in the emergency department. Emerg Med J. 2009 Apr;26(4):273-5. Abstract

28. Benedetti NJ, Desser TS, Jeffrey RB. Imaging of hepatic infections. Ultrasound Q. 2008 Dec;24(4):267-78. Abstract

29. Doyle DJ, Hanbidge AE, O'Malley ME. Imaging of hepatic infections. Clin Radiol. 2006 Dec;61(4):737-48. Abstract

30. Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021 Nov 1;49(11):e1063-143.Full text  Abstract

31. European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. 19 March 2019 [internet publication].Full text

32. Giamarellou H. Multidrug resistance in Gram-negative bacteria that produce extended-spectrum beta-lactamases (ESBLs). Clin Microbiol Infect. 2005 Jul;11(suppl 4):1-16. Abstract

33. Jacoby GA, Munoz-Price LS. The new beta-lactamases. N Engl J Med. 2005 Jan 27;352(4):380-91. Abstract

34. Hope WW, Vrochides DV, Newcomb WL, et al. Optimal treatment of hepatic abscess. Am Surg. 2008 Feb;74(2):178-82. Abstract

35. Liu CH, Gervais DA, Hahn PF, et al. Percutaneous hepatic abscess drainage: do multiple abscesses or multiloculated abscesses preclude drainage or affect outcome? J Vasc Interv Radiol. 2009 Aug;20(8):1059-65. Abstract

36. Pearce N, Knight R, Irving H, et al. Non-operative management of pyogenic liver abscess. HPB (Oxford). 2003;5(2):91-5.Full text  Abstract

37. Yu SC, Ho SS, Lau WY, et al. Treatment of pyogenic liver abscess: prospective randomized comparison of catheter drainage and needle aspiration. Hepatology. 2004 Apr;39(4):932-8.Full text  Abstract

38. Zerem E, Hadzic A. Sonographically guided percutaneous catheter drainage versus needle aspiration in the management of pyogenic liver abscess. AJR Am J Roentgenol. 2007 Sep;189(3):W138-42.Full text  Abstract

39. Aldhafeeri JAA, Alkahtani HHN, Mohammed AA, et al. Percutaneous needle aspiration versus catheter drainage in treating hepatic abscess. The Egyptian Journal of Hospital Medicine. 2018;70:21-8.Full text

40. Tan YM, Chung AY, Chow PK, et al. An appraisal of surgical and percutaneous drainage for pyogenic liver abscesses larger than 5 cm. Ann Surg. 2005 Mar;241(3):485-90.Full text  Abstract

41. Chung YF, Tan YM, Lui HF, et al. Management of pyogenic liver abscesses: percutaneous or open drainage? Singapore Med J. 2007 Dec;48(12):1158-65.Full text  Abstract

42. Hsieh HF, Chen TW, Yu CY, et al. Aggressive hepatic resection for patients with pyogenic liver abscess and APACHE II score > or =15. Am J Surg. 2008 Sep;196(3):346-50. Abstract

43. Sersté T, Bourgeois N, Vanden Eynden F, et al. Endoscopic drainage of pyogenic liver abscesses with suspected biliary origin. Am J Gastroenterol. 2007 Jun;102(6):1209-15. Abstract

44. Ogura T, Masuda D, Saori O, et al. Clinical outcome of endoscopic ultrasound-guided liver abscess drainage using self-expandable covered metallic stent (with video). Dig Dis Sci. 2016 Jan;61(1):303-8. Abstract

45. Haque R, Huston CD, Hughes M, et al. Amebiasis. New Engl J Med. 2003 Apr 17;348(16):1565-73. Abstract

46. Stanley SL Jr. Amoebiasis. Lancet. 2003 Mar 22;361(9362):1025-34. Abstract

47. Chavez-Tapia NC, Hernandez-Calleros J, et al. Image-guided percutaneous procedure plus metronidazole versus metronidazole alone for uncomplicated amoebic liver abscess. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004886.Full text  Abstract

48. Ng FH, Wong WM, Wong BC, et al. Sequential intravenous/oral antibiotic vs. continuous intravenous antibiotic in the treatment of pyogenic liver abscess. Aliment Pharmacol Ther. 2002 Jun;16(6):1083-90.Full text  Abstract

49. Drugs for parasitic infections. Med Lett. 2004 Aug;46:e1-12.

50. Cheng HC, Chang WL, Chen WY, et al. Long-term outcome of pyogenic liver abscess: factors related with abscess recurrence. J Clin Gastroenterol. 2008 Nov-Dec;42(10):1110-5. Abstract

51. Webster J, Osborne S, Rickard CM, et al. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev. 2019 Jan 23;(1):CD007798.Full text  Abstract

52. Fung HB, Doan TL. Tinidazole: a nitroimidazole antiprotozoal agent. Clin Ther. 2005 Dec;27(12):1859-84. Abstract

53. Lucasti C, Vasile L, Sandesc D, et al. Phase 2, dose-ranging study of relebactam with imipenem-cilastatin in subjects with complicated intra-abdominal infection. Antimicrob Agents Chemother. 2016 Oct;60(10):6234-43.Full text  Abstract

54. Ruiz-Hernández JJ, León-Mazorra M, Conde-Martel A, et al. Pyogenic liver abscesses: mortality-related factors. Eur J Gastroenterol Hepatol. 2007 Oct;19(10):853-8. Abstract

55. Chen SC, Huang CC, Tsai SJ, et al. Severity of disease as main predictor for mortality in patients with pyogenic liver abscess. Am J Surg. 2009 Aug;198(2):164-72. Abstract

56. Chen W, Chen CH, Chiu KL, et al. Clinical outcome and prognostic factors of patients with pyogenic liver abscess requiring intensive care. Crit Care Med. 2008 Apr;36(4):1184-8. Abstract

57. Lee SS, Chen YS, Tsai HC, et al. Predictors of septic metastatic infection and mortality among patients with Klebsiella pneumoniae liver abscess. Clin Infect Dis. 2008 Sep 1;47(5):642-50.Full text  Abstract

58. Shiba H, Aoki H, Misawa T, et al. Pneumoperitoneum caused by ruptured gas-containing liver abscess. J Hepatobiliary Pancreat Surg. 2007;14(2):210-1. Abstract

59. Ukikusa M, Inomoto T, Kitai T, et al. Pneumoperitoneum following the spontaneous rupture of a gas-containing pyogenic liver abscess: report of a case. Surg Today. 2001;31(1):76-9. Abstract

60. Ala A, Safar-Aly H, Millar A. Metallic cough and pyogenic liver abscess. Eur J Gastroenterol Hepatol. 2001 Aug;13(8):967-9. Abstract

61. Costi R, Bataille N, Cazaban A, et al. Image of the month: cholecystocolonic fistula associated with Escherichia coli liver abscess. Arch Surg. 2009 May;144(5):481-2. Abstract

62. Chung SD, Chen KH, Chang HC. Pyelo-hepatic fistula. Urology. 2008 Sep;72(3):524. Abstract

63. Monge-Fresse AS, Siriez JY, Bricaire F. Spontaneous fistulisation of a liver abscess into the stomach. Neth J Med. 2007 Dec;65(11):456-7. Abstract

64. Syed MA, Kim TK, Jang HJ. Portal and hepatic vein thrombosis in liver abscess: CT findings. Eur J Radiol. 2007 Mar;61(3):513-9. Abstract

Use of this content is subject to our disclaimer